Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy
Paola Faverio, Giulia Bonaiti, Francesco Bini, et al.
Therapeutics and Clinical Risk Management (2018) Vol. Volume 14, pp. 2385-2396
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Diagnostic and Therapeutic Challenges
Mohammad Ali Sadiq, Graeme K. Loh, Yasir J. Sepah, et al.
Retina (2014) Vol. 35, Iss. 6, pp. 1279-1282
Closed Access | Times Cited: 219
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
Alessandra Bettiol, Maria Letizia Urban, Lorenzo Dagna, et al.
Arthritis & Rheumatology (2021) Vol. 74, Iss. 2, pp. 295-306
Open Access | Times Cited: 120
Eosinophilic Dermatoses: Recognition and Management
Angelo Valerio Marzano, Giovanni Genovese
American Journal of Clinical Dermatology (2020) Vol. 21, Iss. 4, pp. 525-539
Closed Access | Times Cited: 45
Risks and benefits of corticosteroids in arthritic diseases in the clinic
Ιωάννα Πέττα, Isabelle Peene, Dirk Elewaut, et al.
Biochemical Pharmacology (2019) Vol. 165, pp. 112-125
Closed Access | Times Cited: 36
Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series
Aikaterini Detoraki, Eugenio Tremante, Remo Poto, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 31
Perspectives on the Efficacy of Benralizumab for Treatment of Eosinophilic Granulomatosis With Polyangiitis
Yasuhiko Koga, Haruka Aoki‐Saito, Yosuke Kamide, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Pathophysiology and therapy of systemic vasculitides.
Massimo Ralli, Flaminia Campo, Diletta Angeletti, et al.
PubMed (2020) Vol. 19, pp. 817-854
Closed Access | Times Cited: 26
Successful mepolizumab treatment for DRESS-induced refractory eosinophilic myocarditis and concurrent thyroiditis
Kelvin Truong, Shane Kelly, Angela Bayly, et al.
BMJ Case Reports (2021) Vol. 14, Iss. 7, pp. e242240-e242240
Open Access | Times Cited: 18
Rituximab and mepolizumab combination therapy for glucocorticoid-resistant myocarditis related to eosinophilic granulomatosis with polyangiitis
Kana Higashitani, Ryusuke Yoshimi, Yuichiro Sato, et al.
Modern Rheumatology Case Reports (2021) Vol. 6, Iss. 1, pp. 87-92
Open Access | Times Cited: 18
Rapid onset of effect of benralizumab on respiratory symptoms in a patient with eosinophilic granulomatosis with polyangiitis
Angelo Coppola, Krisstopher Richard Flores, Francesca De Filippis
Respiratory Medicine Case Reports (2020) Vol. 30, pp. 101050-101050
Open Access | Times Cited: 17
Early add‐on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis
Takaharu Ikeda, Toshiro Komatsu, Kae Yokoyama, et al.
The Journal of Dermatology (2020) Vol. 48, Iss. 4, pp. 529-532
Closed Access | Times Cited: 17
The Role of T Helper Type 2 (Th2) Cytokines in the Pathogenesis of Eosinophilic Granulomatosis with Polyangiitis (eGPA): an Illustrative Case and Discussion
Megan E. Milne, Jack Kimball, Teresa K. Tarrant, et al.
Current Allergy and Asthma Reports (2022) Vol. 22, Iss. 11, pp. 141-150
Open Access | Times Cited: 10
A Pediatric Case of Relapsing Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab
Mizuho Nara, Masaya Saito, Fumito Abe, et al.
Internal Medicine (2019) Vol. 58, Iss. 24, pp. 3583-3587
Open Access | Times Cited: 17
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis
Daniel B. Ennis, Jason Kihyuk Lee, Christian Pagnoux
Expert Opinion on Biological Therapy (2019) Vol. 19, Iss. 7, pp. 617-630
Closed Access | Times Cited: 15
Concurrent Use of Mepolizumab and Rituximab for Eosinophilic Granulomatosis With Polyangiitis and Multisystem Involvement
Agura Afiari, Andre Gabriel, Meghana R Gaiki
Cureus (2020)
Open Access | Times Cited: 14
Mepolizumab as a glucocorticoid-sparing agent in eosinophilic granulomatosis with polyangiitis (EGPA): is a lower dose sufficient?
Mirna Vergles, Zinka Matković, Kristina Lalić, et al.
Journal of Asthma (2020) Vol. 58, Iss. 12, pp. 1675-1679
Closed Access | Times Cited: 14
Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship
Alessandro Maria Marra, Pietro Curci, Giovanni Franco, et al.
Cureus (2024)
Open Access | Times Cited: 1
B-Cell-Depleting Therapy Improves Myocarditis in Seronegative Eosinophilic Granulomatosis with Polyangiitis
Chrong‐Reen Wang, Yi‐Shan Tsai, Hung‐Wen Tsai, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4577-4577
Open Access | Times Cited: 10
Effective treatment with mepolizumab in a patient with severe eosinophilic granulomatosis with polyangiitis complicated with small intestine perforation
Mari Sato, Masakiyo Yatomi, Ikuo Wakamatsu, et al.
Respiratory Medicine Case Reports (2023) Vol. 43, pp. 101818-101818
Open Access | Times Cited: 3
Embryologie, Fehlbildungen und seltene Erkrankungen der Cochlea
Athanasia Warnecke, Anja Giesemann
Laryngo-Rhino-Otologie (2021) Vol. 100, Iss. S 01, pp. S1-S43
Open Access | Times Cited: 7
Biologic Treatments for Asthma and Chronic Obstructive Pulmonary Disorder
Misa Kusumoto, Bryan J. Mathis
Allergies (2021) Vol. 1, Iss. 2, pp. 92-107
Open Access | Times Cited: 6
Severe eosinophilic granulomatosis with polyangiitis responding to a combination of rituximab and mepolizumab
Georgios Tsioulos, Dimitris Kounatidis, Natalia G. Vallianou, et al.
The American Journal of the Medical Sciences (2022) Vol. 365, Iss. 1, pp. 93-98
Closed Access | Times Cited: 4
Benralizumab as a Potential Adjunctive Therapy in Eosinophilic Granulomatosis With Polyangiitis
Yvonne Lee, Mehrnaz Hojjati
JCR Journal of Clinical Rheumatology (2020) Vol. 27, Iss. 8S, pp. S401-S402
Open Access | Times Cited: 5
Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
Giuseppe A. Ramirez, Adriana Cariddi, Silvia Noviello, et al.
Clinical Immunology Communications (2022) Vol. 2, pp. 23-29
Open Access | Times Cited: 3
Severe heart failure and intracardiac thrombosis: going beyond the appearance for diagnosis and treatments
Andrea Segreti, Sara Mastroberardino, Lorenzo Frau, et al.
Monaldi Archives for Chest Disease (2024)
Open Access
Page 1 - Next Page

Scroll to top